(Q50558415)

15 March 2018

title

The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis C. (English)

1 reference

15 March 2018

0 references

A G Vigani

1

1 reference

15 March 2018

A Macedo de Oliveira

2

1 reference

15 March 2018

R Tozzo

3

1 reference

15 March 2018

M H P Pavan

4

1 reference

15 March 2018

E S Gonçales

5

1 reference

15 March 2018

V Fais

6

1 reference

15 March 2018

N S Gonçales

7

1 reference

15 March 2018

F L Gonçales

8

1 reference

15 March 2018

publication date

25 October 2010

1 reference

15 March 2018

Journal of Viral Hepatitis

published in

1 reference

15 March 2018

volume

18

1 reference

15 March 2018

issue

4

1 reference

15 March 2018

page(s)

e91-8

1 reference

15 March 2018

Epidemiology of hepatitis C: geographic differences and temporal trends

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Consensus among consensus conferences on management of hepatitis C: what we knew then and are still sure about, what we are newly sure about, and what we still need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Cryoglobulinemia in Japanese patients with chronic hepatitis C virus infection: host genetic and virological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Immunological aspects of HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Chronic hepatitis C virus in the state of Piauí, northeastern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Lower th-1/th-2 ratio before interferon therapy may favor long-term virological responses in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Viral and host immune regulatory mechanisms in hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

Type I interferons inhibit interleukin-10 production in activated human monocytes and stimulate IL-10 in T cells: implications for Th1-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01385.X

10.1111/J.1365-2893.2010.01385.X

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018